Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292


Real-time Estimate Quote. Real-time Estimate CHI-X - 11/24 11:30:00 am
8004 GBX   +0.05%
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
04:57pOil closes at highest level since March on vaccine trials, Biden transition
04:43pDow Jones Industrial Average Crosses 30000 for First Time
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Travel, energy stocks drag UK shares lower, weighed by coronavirus fears

10/26/2020 | 05:26am EST

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)

* Surge in coronavirus cases dents mood

* EU negotiator Barnier extends London visit for Brexit talks

* AstraZeneca gains on positive COVID-19 vaccine update

* Coca-Cola European Partners rise on buyout offer

* FTSE 100 down 1.2%, FTSE 250 drops 1.4%

Oct 26 (Reuters) - London stocks closed sharply lower on Monday, weighed by travel and energy stocks, while a resurgence in novel coronavirus cases stoked fears of a faltering economic recovery and dragged down European markets. After rising nearly 0.1% in morning trade, the blue-chip FTSE 100 index fell 1.2%, led by declines in travel and leisure, personal goods makers, retailers and aero stocks.

Energy and mining weighed the most on the index due to weaker commodity prices.

The domestically focussed mid-cap FTSE 250 index lost 1.4% even as European Union chief negotiator Michel Barnier and his team extended their London visit until Wednesday to try and clinch a Brexit trade deal.

European markets were weighed down by a plunge in tech major SAP, an impasse over the U.S. stimulus package and fears that a resurgence in coronavirus cases could hamper a global economic recovery as governments tighten restrictions on businesses and social activity.

"The fact that (more) countries are now reining in the freedom of people to move around is going to have a detrimental impact on the actual overall activity level in the economy", said Saxo Bank chief investment officer Steen Jakobsen.

"UK is even more challenged due to the COVID-19 close-down and Brexit."

After a stimulus-backed rally from pandemic lows, the FTSE 100 has been trading in tight ranges since June due to Brexit-related uncertainty and concerns over coronavirus curbs.

In a bright spot, AstraZeneca Plc rose 1.7% after the drugmaker resumed the U.S. trial of its experimental COVID-19 vaccine that is being developed with the University of Oxford, and said it produced a similar immune response in both older and younger adults.

The wider healthcare index added 1%.

Educational publisher Pearson Plc added 3% after UBS upgraded the stock to a "buy" rating.

Coca-Cola European Partners (CCEP) rose 0.3% after the soft drink bottler made a buyout offer of $6.6 billion for its Australian peer Coca-Cola Amatil Ltd. (Reporting by Devik Jain in Bengaluru; editing by Aditya Soni and Bernadette Baum)

© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.00% 8000 Delayed Quote.5.17%
COCA-COLA AMATIL LIMITED 0.16% 12.59 End-of-day quote.13.83%
EURO / BRITISH POUND (EUR/GBP) 0.17% 0.89022 Delayed Quote.5.48%
MSCI UNITED KINGDOM (STRD, UHD) 2.05% 1007.138 Real-time Quote.-16.96%
PEARSON PLC 4.21% 652.8 Delayed Quote.-1.66%
SAP SE -0.95% 97.35 Delayed Quote.-18.32%
All news about ASTRAZENECA PLC
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
04:57pOil closes at highest level since March on vaccine trials, Biden transition
04:43pDow Jones Industrial Average Crosses 30000 for First Time
03:29pAccelerating Rally in Oil Prices Signals Optimism About Global Growth
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
02:31pANALYSIS : Dow cracks 30,000, a psychological boost during a pandemic
02:01pASTRAZENECA : Correction to AstraZeneca Vaccine Article
01:20pUPS Preparing to Help Ship, Store Covid-19 Vaccines
01:16pNEWS HIGHLIGHTS : Top Company News of the Day
12:43pEuropean shares end at near nine-month high on potential easing of virus curb..
More news
Financials (USD)
Sales 2020 26 560 M - -
Net income 2020 3 076 M - -
Net Debt 2020 13 252 M - -
P/E ratio 2020 35,8x
Yield 2020 3,52%
Capitalization 105 B 140 B -
EV / Sales 2020 4,45x
EV / Sales 2021 3,87x
Nbr of Employees 70 600
Free-Float 95,7%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 121,58 $
Last Close Price 80,00 $
Spread / Highest target 94,3%
Spread / Average Target 52,0%
Spread / Lowest Target -17,5%
EPS Revisions
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-3.77%283 004
MERCK & CO., INC.-11.73%203 111
PFIZER INC.-6.79%202 993
NOVARTIS AG-13.38%198 168